La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Insulet Croissance future
Future contrôle des critères 2/6
Insulet devrait augmenter ses bénéfices et son chiffre d'affaires de 3.2% et de 14.3% par an respectivement. Le BPA devrait croître de de 1.3% par an. Le rendement des capitaux propres devrait être 19.4% dans 3 ans.
Informations clés
3.2%
Taux de croissance des bénéfices
1.3%
Taux de croissance du BPA
| Medical Equipment croissance des bénéfices | 17.4% |
| Taux de croissance des recettes | 14.3% |
| Rendement futur des capitaux propres | 19.4% |
| Couverture par les analystes | Good |
| Dernière mise à jour | 14 Aug 2024 |
Mises à jour récentes de la croissance future
Recent updates
Additional Considerations Required While Assessing Insulet's (NASDAQ:PODD) Strong Earnings
Aug 16
A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Jul 15Insulet Corporation: Insulin Pump Provider Fighting Back After Torrid 2023
Jun 11We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)
May 26At US$166, Is It Time To Put Insulet Corporation (NASDAQ:PODD) On Your Watch List?
May 12Is Insulet (NASDAQ:PODD) A Risky Investment?
Apr 29Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Apr 14Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD)
Mar 31Insulet: Insulating Patients, Investors Still Have To Wait
Mar 28Insulet (NASDAQ:PODD) Is Doing The Right Things To Multiply Its Share Price
Feb 19Is Insulet Corporation (NASDAQ:PODD) Potentially Undervalued?
Jan 22Insulet: An Interesting, Yet Expensive, Story
Jan 10Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jan 09Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Dec 27Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Nov 14Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue
Oct 31We Think Insulet (NASDAQ:PODD) Is Taking Some Risk With Its Debt
Oct 01Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?
Sep 16Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Aug 14Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
Jul 31Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jun 18Getting In Cheap On Insulet Corporation (NASDAQ:PODD) Might Be Difficult
May 22Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
Apr 30Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt Burden
Jan 24Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue
Dec 28Insulet: An Overpriced Play In The Medical Space
Oct 18Insulet (NASDAQ:PODD) Has A Pretty Healthy Balance Sheet
Oct 02Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2026 | 2,791 | 366 | 381 | 477 | 17 |
| 12/31/2025 | 2,376 | 286 | 310 | 382 | 21 |
| 12/31/2024 | 2,011 | 379 | 280 | 377 | 21 |
| 6/30/2024 | 1,873 | 395 | 182 | 285 | N/A |
| 3/31/2024 | 1,781 | 234 | 137 | 233 | N/A |
| 12/31/2023 | 1,697 | 206 | 37 | 146 | N/A |
| 9/30/2023 | 1,557 | 120 | -15 | 151 | N/A |
| 6/30/2023 | 1,465 | 63 | -26 | 152 | N/A |
| 3/31/2023 | 1,368 | 1 | -45 | 133 | N/A |
| 12/31/2022 | 1,305 | 5 | -38 | 119 | N/A |
| 9/30/2022 | 1,243 | 17 | -63 | 43 | N/A |
| 6/30/2022 | 1,178 | 35 | -141 | -40 | N/A |
| 3/31/2022 | 1,142 | 45 | -152 | -47 | N/A |
| 12/31/2021 | 1,099 | 17 | -191 | -68 | N/A |
| 9/30/2021 | 1,037 | -29 | -199 | -26 | N/A |
| 6/30/2021 | 996 | -30 | -126 | 44 | N/A |
| 3/31/2021 | 959 | 9 | -120 | 53 | N/A |
| 12/31/2020 | 904 | 7 | -82 | 84 | N/A |
| 9/30/2020 | 868 | 29 | -15 | 114 | N/A |
| 6/30/2020 | 826 | 18 | -25 | 101 | N/A |
| 3/31/2020 | 777 | 5 | -65 | 88 | N/A |
| 12/31/2019 | 738 | 12 | -72 | 98 | N/A |
| 9/30/2019 | 694 | 17 | -74 | 82 | N/A |
| 6/30/2019 | 653 | 17 | -103 | 67 | N/A |
| 3/31/2019 | 600 | 14 | -126 | 47 | N/A |
| 12/31/2018 | 564 | 3 | -126 | 36 | N/A |
| 9/30/2018 | 529 | -13 | -130 | 27 | N/A |
| 6/30/2018 | 500 | -17 | -93 | 35 | N/A |
| 3/31/2018 | 486 | -23 | N/A | 59 | N/A |
| 12/31/2017 | 464 | -27 | N/A | 41 | N/A |
| 9/30/2017 | 437 | -29 | N/A | 39 | N/A |
| 6/30/2017 | 410 | -30 | N/A | 19 | N/A |
| 3/31/2017 | 387 | -26 | N/A | 5 | N/A |
| 12/31/2016 | 367 | -27 | N/A | 16 | N/A |
| 9/30/2016 | 347 | -34 | N/A | -23 | N/A |
| 6/30/2016 | 324 | -49 | N/A | -17 | N/A |
| 3/31/2016 | 297 | -62 | N/A | -20 | N/A |
| 12/31/2015 | 264 | -62 | N/A | -13 | N/A |
| 9/30/2015 | 253 | -51 | N/A | 11 | N/A |
| 6/30/2015 | 256 | -44 | N/A | 7 | N/A |
| 3/31/2015 | 268 | -56 | N/A | 6 | N/A |
| 12/31/2014 | 231 | -48 | N/A | 9 | N/A |
| 9/30/2014 | 285 | -49 | N/A | 1 | N/A |
| 6/30/2014 | 271 | -59 | N/A | 0 | N/A |
| 3/31/2014 | 259 | -40 | N/A | 4 | N/A |
| 12/31/2013 | 247 | -45 | N/A | 3 | N/A |
| 9/30/2013 | 236 | -53 | N/A | 1 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: PODD's forecast earnings growth (3.2% per year) is above the savings rate (2.5%).
Bénéfices vs marché: PODD's earnings (3.2% per year) are forecast to grow slower than the US market (15.1% per year).
Croissance élevée des bénéfices: PODD's earnings are forecast to grow, but not significantly.
Chiffre d'affaires vs marché: Le chiffre d'affaires de PODD ( 14.3% par an) devrait croître plus rapidement que le marché US ( 8.7% par an).
Croissance élevée des revenus: Le chiffre d'affaires de PODD ( 14.3% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: PODD's Return on Equity is forecast to be low in 3 years time (19.4%).